Technical Data
B1075-03
Benzodiazepine (Oxazepam)
Description:
The term benzodiazepine refers to the portion of the structure composed of a benzene ring fused to a seven membered diazepine ring. Benzodiazepine is a central nervous system depressants, a sedative hypnotic agent. Benzodiazepine receptors are located on the alpha subunit of the GABA receptor located almost exclusively on postsynaptic nerve endings in the CNS (especially cerebral cortex). Benzodiazepines enhance the GABA transmitter in the opening of postsynaptic chloride channels which leads to hyperpolarization of cell membranes.

Applications:
Suitable for use in ELISA and Lateral gold conjugation. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Matched Pairs:
Capture: B1075-02
Detection: B1075-03
Suitable for use as the capture or solid phase antibody.
Matched to B1075-02 as the detection or conjugate (label) antibody.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG1,k3C97Purified
SizeStorageShippingSourceHost
1mg-20CBlue IceMouse
Concentration:
~3mg/ml
Immunogen:
Benzodiazepine
Purity:
Purified
Form
Supplied as a liquid in PBS, pH 7.2, 0.05% sodium azide.
Specificity:
Recognizes Benzodiazepine
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.